ImmuCell Corporation Revenue Breakdown
No Revenue Breakdown for ICCC on this site yet.
- 2025-12-31: Others Not split by product in the filing$27.64M100.00%; Total revenue $27.64M.
- 2024-12-31: Others Not split by product in the filing$26.49M100.00%; Total revenue $26.49M.
- 2023-12-31: Others Not split by product in the filing$17.47M100.00%; Total revenue $17.47M.
- 2022-12-31: Others Not split by product in the filing$18.57M100.00%; Total revenue $18.57M.
Source checked: the stored Revenue Breakdown page for ICCC.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $27.64M 100.00% | $27.64M |
| 2024-12-31 | Not split by product in the filing $26.49M 100.00% | $26.49M |
| 2023-12-31 | Not split by product in the filing $17.47M 100.00% | $17.47M |
| 2022-12-31 | Not split by product in the filing $18.57M 100.00% | $18.57M |
| 2021-12-31 | Not split by product in the filing $19.24M 100.00% | $19.24M |
| 2020-12-31 | Not split by product in the filing $15.34M 100.00% | $15.34M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $7.19M 100.00% | $7.19M |
| 2026-03-31 | Not split by product $10.36M 100.00% | $10.36M |
| 2025-12-31 | Not split by product $7.63M 100.00% | $7.63M |
| 2025-09-30 | Not split by product $5.51M 100.00% | $5.51M |
| 2025-06-30 | Not split by product $6.44M 100.00% | $6.44M |
| 2025-03-31 | Not split by product $8.07M 100.00% | $8.07M |
| 2024-12-31 | Not split by product $7.75M 100.00% | $7.75M |
| 2024-09-30 | Not split by product $6.01M 100.00% | $6.01M |
| 2024-06-30 | Not split by product $5.47M 100.00% | $5.47M |
| 2024-03-31 | Not split by product $7.26M 100.00% | $7.26M |
| 2023-12-31 | Not split by product $0.00 | $0.00 |
| 2023-09-30 | Not split by product $5.40M 100.00% | $5.40M |
| 2022-12-31 | Not split by product $3.91M 100.00% | $3.91M |
| 2022-09-30 | Not split by product $4.80M 100.00% | $4.80M |
| 2021-12-31 | Not split by product $5.44M 100.00% | $5.44M |
| 2021-09-30 | Not split by product $5.15M 100.00% | $5.15M |
| 2018-06-30 | Not split by product $3.01M 100.00% | $3.01M |
| 2018-03-31 | Not split by product $2.88M 100.00% | $2.88M |
| 2017-06-30 | Not split by product $1.75M 100.00% | $1.75M |
| 2017-03-31 | Not split by product $3.54M 100.00% | $3.54M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |